Toggle light / dark theme

Could this common painkiller become a future cancer-killer?

Cancer cells (credit: iStock)

Diclofenac, a common painkiller, has significant anti-cancer properties, researchers from the Repurposing Drugs in Oncology (ReDO) project have found.

ReDO, an international collaboration between the Belgium-based Anticancer Fund and the U.S.- based GlobalCures, has published their investigation into diclofenac in the open-access journal ecancermedicalscience.

Read more

Gene Editing Treats Disease In A Living Animal For The First Time

In a landmark study, researchers have used gene editing system CRISPR-Cas9 to treat a model of Duchenne muscular dystrophy in mice

Proof of concept for future human treatment

While safety is still a concern, the use of gene editing methods to treat disease in adult patients isn’t controversial. Altering embryos is entirely different to treating an adult, predominantly as the implications are profound and an embryo obviously cannot give permission.

Read more

/* */